- DEA plans a temporary Schedule I ban on 7‑hydroxymitragynine (7‑OH) and three synthetic derivatives—putting them in the same category as heroin/LSD (two-year action, possible extension).
- Officials warn many products sold as “kratom extracts” (gummies, candies, liquid shots) actually contain synthetic opioids and could appeal to kids and teens.
- Botanical kratom itself isn’t being scheduled, but the FDA cautions against kratom use because of risks like addiction, liver damage and seizures.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.